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Introduction
The usefulness of plasma cobalamin in diagnosing cobalamin deficiency has been extensively discussed and it is generally accepted that it cannot be used as a sole criterion for cobalamin deficiency [1±6] . Plasma methylmalonic acid (P-MMA) has been proposed to be a more specific and sensitive marker than plasma cobalamin [4, 7±9] and has therefore been increasingly used as an alternative or supplementary test during the past 10 years.
It has been suggested that cobalamin deficiency should be defined as an increased P-MMA that decreases upon treatment with cobalamin [6, 10, 11] . This criterion is not generally accepted, however, and some have expressed the concern that this use of P-MMA may result in treatment of biochemical changes of no clinical importance [12, 13] . P-MMA is elevated in patients with impaired kidney function, as expressed by elevated plasma creatinine [10, 14±16] . However, little is known about the association between P-MMA and plasma creatinine in the whole range of values of plasma creatinine. This is an important issue since one precondition for P-MMA to be a superior test for diagnosis of cobalamin deficiency is that it is unaffected, or affected in a simple way, by factors other than cobalamin deficiency.
We examined the relationship between P-MMA and plasma cobalamins, age, sex and plasma creatinine. Our most important finding is a strong correlation between P-MMA and plasma creatinine over the entire range of values for plasma creatinine.
Materials and methods
All records with P-MMA, plasma cobalamins and plasma creatinine were extracted from the laboratory information systems at Aarhus University Hospital. We selected the records for 1689 patients who had P-MMA and plasma cobalamins requested on the same day during 1995±96. Only the first P-MMA measurement for each patient was included. The purpose of this restriction was to obtain data representing unselected and untreated patients with some suspicion of cobalamin deficiency. Plasma creatinine values measured within 7 days before or after the index measurements were available for 1255 patients. P-MMA was determined by gas chromatographymass spectrometry [17] , and the reference interval for P-MMA was 0.08±0.28 mmol L 21 [18] . The coefficient of variation was 7.9% for P-MMA [17] . Plasma cobalamins were determined using human intrinsic factor as binding protein [19] , and the reference interval was 200±600 pmol L 21 [20] . Plasma creatinine was measured with Jaffe Âs method using a Roche Cobas Integra 700 autoanalyser, or by a dry-slide enzymatic method using a Vitros 950 autoanalyser (Johnson & Johnson Clinical Diagnostics). The reference interval was 55±120 mmol L 21 . The coefficient of variation for plasma creatinine was about 2%.
We used Mantel±Haenszel's test for trend to examine the association between ordinal variables, and Pearson's correlation and multiple linear regression analysis to examine the association between continuous variables. Log transformations were used when appropriate. Data were analysed with SPSS. Table 1 shows the distributions of age, P-MMA, plasma cobalamins and plasma creatinine. The majority of patients were above 60 years old, and 62% were females. Thirty per cent had a concentration of P-MMA above 0.28 mmol L 21 and 18% had plasma cobalamins below 200 pmol L 21 . Ninety per cent of the patients had plasma creatinine below 120 mmol L 21 . Fifty-nine per cent of the P-MMA tests were requested by physicians in hospitals and 41% by general practitioners. There were no substantial differences in test results and age distribution between the hospital and general practitioner groups. Figure 1 and Table 2 show the joint distribution of P-MMA and plasma cobalamins. The correlation between P-MMA and plasma cobalamins was strong for plasma cobalamins below 200 pmol L Plasma cobalamins declined and P-MMA and plasma creatinine increased with age. There was a 5 0 8 A . M . H V A S et al. weak positive association of plasma cobalamins with plasma creatinine (r = 0.05, P = 0.06). The dependency of P-MMA on plasma cobalamins, plasma creatinine, age and sex was further analysed with multiple linear regression, Table 3 . Plasma cobalamins, plasma creatinine and age were strong and independent predictors of P-MMA, whilst sex was a weak predictor. Thirty-one per cent of the variation of P-MMA could be explained by these variables. Seventeen outliers (P-MMA . 2.00 mmol L 21 ) were excluded, and after this exclusion, residual analysis demonstrated a good fit to the regression model. No statistical interactions (effect modification) were found, as the coefficients estimated were similar for old and young, males and females, patients with high and low plasma creatinine, and high and low plasma cobalamins.
Results
The regression coefficients were used to predict the level of P-MMA from plasma cobalamins, plasma creatinine, sex and age. To illustrate the effect of plasma cobalamins and plasma creatinine, Fig. 2 shows the predicted P-MMA (geometric mean) at various levels of plasma creatinine and plasma cobalamins for 70-year-old women. A 10% decline in plasma cobalamins corresponded to a 3% increase in P-MMA, whilst a 10% increase in plasma creatinine corresponded to a 6% increase in P-MMA.
For a patient with low plasma cobalamins (150 pmol L 21 ) and a low plasma creatinine (50 mmol L 21 ), the predicted P-MMA was within the reference interval (0.22 mmol L 21 ), whilst for a patient with normal plasma cobalamins (250 pmol L 21 ) and a high normal plasma creatinine (100 mmol L 21 ), the predicted P-MMA was just above the reference interval (0.29 mmol L 21 ). The association between plasma creatinine and P-MMA is also illustrated in Table 4 . In patients with low and with normal plasma cobalamins, the proportion with elevated P-MMA increased with the level of plasma creatinine. Thus the discrepan- cies shown in Table 2 between P-MMA and plasma cobalamin findings can partly, but not entirely, be explained by variations in plasma creatinine. Keeping in mind the absence of a definite criterion of cobalamin deficiency, the results in Table 4 express the sensitivity and specificity of P-
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in predicting plasma cobalamins , 200 pmol L 21 . With plasma creatinine below 80 mmol L 21 , the sensitivity was 44% and the specificity 83%, whilst with plasma creatinine in the interval 100±119 mmol L 21 , the sensitivity was 73% and the specificity 74%.
Discussion
A large number of simultaneously determined plasma cobalamins and P-MMA values allowed a thorough analysis of the relationship between the two variables and of the influence of possible confounding factors such as sex, age and plasma creatinine.
Our most prominent finding is a strong association between P-MMA and plasma creatinine also within the normal range for plasma creatinine. In contrast, no significant association was found between plasma cobalamins and plasma creatinine. We believe the results to be of special relevance for patients with decreased plasma cobalamins. In these patients, P-MMA may be within the current reference interval if plasma creatinine is low-normal (illustrated in Fig. 2) . Our results suggest that plasma creatinine needs to be taken into consideration when interpreting P-MMA.
Some have suggested that normal levels of both P-MMA and plasma homocysteine rule out clinically significant cobalamin deficiency [16, 21] . In the light of our study, we agree with others who state that we do not yet know how confidently we can exclude cobalamin deficiency disease when plasma cobalamins are low and P-MMA is normal [13] . In agreement with some previous studies [20, 22± 24] , we observed decreasing plasma cobalamins and increasing levels of P-MMA with advancing age. The influence of sex was marginal. As shown by previous studies on smaller samples [9, 21, 22] we found a significant correlation between plasma cobalamins and P-MMA at plasma cobalamin levels below 200 pmol L 21 . However, the discrepancy was substantial between results obtained by the two tests. The relationship between P-MMA and plasma creatinine may explain some of this discrepancy, but is unlikely to be the only explanation.
Elevated P-MMA with normal plasma cobalamins might reflect poor specificity of P-MMA or poor sensitivity of plasma cobalamins in diagnosing cobalamin deficiency. It has been argued for years that the sensitivity of plasma cobalamins is low [1, 2] and it is well known that P-MMA may be high in conditions not related to cobalamin deficiency. An increased P-MMA is seen in renal insufficiency [14± 16], thyroid disease, small bowel bacterial overgrowth, and conditions with haemoconcentration [25] , but the frequency of non-specific elevations in P-MMA due to these reasons is unknown. As noted by Chanarin and Metz [12] the specificity of P-MMA has not been adequately evaluated.
A recent study by Lindgren et al. [26] did not find a higher specificity and sensitivity of increased P-MMA compared with low plasma cobalamins for identifying patients with conditions compatible with cobalamin malabsorption. These findings are in strong contrast with earlier studies claiming much higher sensitivity of abnormal P-MMA concentrations compared with low plasma cobalamins [22, 27, 28] . The study by Lindgren et al. [26] and our findings emphasize that the interpretation of P-MMA is still a key question.
In conclusion, the interpretation of P-MMA and plasma cobalamins is still uncertain, as is the strategy for diagnosing cobalamin deficiency. Obviously our study does not enable one to determine whether the combination of P-MMA and plasma creatinine could give clinically more relevant information than do plasma cobalamin measurements. But the study strongly suggests that plasma creatinine must be included when assessing P-MMA, and reference intervals not taking age and plasma creatinine into account can be misleading. 
